Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standardized sTudy With Almotriptan in eaRly Treatment of Migraine, START. An International, Open-label, Single Arm, Effectiveness and Safety Study of Almotriptan in Primary Care Setting

NCT00725140 is registered in ClinicalTrials.gov with Almirall, S.A. as lead sponsor.

NCT NCT00725140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00725140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standardized sTudy With Almotriptan in eaRly Treatment of Migraine, START. An International, Open-label, Single Arm, Effectiveness and Safety Study of Almotriptan in Primary Care Setting
Lead sponsor
Almirall, S.A.
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2009
Enrollment
501 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

migraine